Skip to main content
Premium Trial:

Request an Annual Quote

FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

NEW YORK ─ The US Food and Drug Administration on Friday reissued an Emergency Use Authorization for the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit and expanded it to include an additional sample collection kit provided by Austin, Texas-based Everlywell as well as a new workflow.

In March, Thermo Fisher's test was the second commercial diagnostic assay to be granted EUA.

The TaqPath test is now authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens when determined by a healthcare provider to be appropriate based on results of a COVID-19 questionnaire, Waltham, Massachusetts-based Thermo Fisher said in a statement.

Samples collected using the Everlywell self-collection kit may be processed by CLIA-certified laboratories running Thermo Fisher's TaqMan SARS-CoV-2 RNase P Assay Kit, and the results obtained through the Everlywell online platform, Thermo Fisher said. More convenient home-collection sample processing is expected to increase access to PCR-based testing and complement other defensive measures including good hygiene, social distancing, and wearing a mask, the firm added.

The FDA said that it further revised the EUA to add a workflow with increased purified RNA input volume.

Everlywell received EUA for its COVID-19 Test Home Collection Kit in May.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.